The EMA validation of T-DXd with pertuzumab could change the standard of care for HER2-positive metastatic breast cancer in ...

Looking for a smart life solution, with just verbal communication via a 24/7 personal assistant that actually understands ...

NEW YORK, NY / ACCESS Newswire / January 19, 2026 / In the 21st century, every business working with diverse clients from very different industries continues to see how important it is for brands to ...